As predicted, the initiation of phase 2 is now due to start in the 2nd qtr of 2022 when last year they were advertsing tge start in Q1 of 2022.
i dont think they have ever met a timeline target. All announcements these days are about poster to presentations of old data or attendances at conferences.
The new announcement is more to do with diagnostic findings rather than therapeutic. I look forward to the day that PBT434 shows significant improvements to the day to day life of MSA sufferers.
Ann: Presentation of bioMUSE Data at the AAN Annual Meeting, page-3
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.62M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $5.503K | 1.808M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 46 | 56169934 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 123582868 | 22 |
View Market Depth
| Last trade - 12.21pm 03/09/2024 (20 minute delay) ? |
| ATH (ASX) Chart |